Osteogenics Biomedical, Inc., a subsidiary of Envista Holdings Corp., is a company headquartered in Lubbock, TX, that engages in dental equipment and supplies. The firm was acquired by Envista Holdings Corp. on July 05, 2022.

Qingdao Huisheng Huizhong Biotechnology Co., Ltd., established on 2015-07-08, Business scope includes bioengineering technology development,Biomaterials R&D,Biological product production technology development and technology promotion services,new material technology,Biotechnology Extension Services,retail:Biological product(Does not contain drugs),chemical reagent,Experimental consumables,laboratory apparatus.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qingdao Healthy Marine Bio-Pharmaceutical Co., Ltd., established on 2015-08-14, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Drug Wholesale;Drug retail;food production;food sales;Health food production;Cosmetic production;Disinfectant production(Free of Hazardous Chemicals);Production of disinfection products for the prevention and control of infectious diseases;Disinfection equipment sales;Production of hygiene products and single-use medical products;Production of medical masks;Production of protective equipment for medical personnel(Class II medical device);feed production;Veterinary drug production;Veterinary drug business;Internet Information Service for Medical Devices;Food Internet Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical Mask Retail;Wholesale medical masks;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Manufacturing of daily chemical products;Daily necessities sales;Sales of daily chemical products;General merchandise sales;daily mask(non-medical)Production;daily mask(non-medical)Sales;Wholesale of protective equipment for medical staff;Production of protective equipment for medical personnel(Ι class medical device);Maternal and baby products sales;Cosmetics Retail;Cosmetics Wholesale;Disinfectant sales(Free of Hazardous Chemicals);Personal Hygiene Sales;Sales of hygiene products and single-use medical products;Manufacture of technical textile products;Sales of industrial textile products;Manufacturing of bio-based materials;Research and development of bio-based materials technology;Sales of bio-based materials;Veterinary special equipment sales;Pet food and supplies retail;Pet Food and Supplies Wholesale;Feed Raw Material Sales;Bio-feed R&D;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);internet sales(Except for products that require a license for sale);Food Internet Sales(Only sell prepackaged food);Food Additive Sales;Technology Import and Export;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Shanghai Treeful Pharmaceutical Co. Ltd., a subsidiary of China Resources Double-Crane Pharmaceutical Co., Ltd., is a company headquartered in Shanghai, China. The firm manufactures pharmaceutical products. It was acquired by China Resources Double-Crane Pharmaceutical Co., Ltd. from China Resources National Corp. on November 08, 2011 for $14.50 million.

Provides pharmaceutical products based on therapeutic peptides

Novo Biotechnology (Tianjin) Co., Ltd., established on 2017-02-24, Business scope includes prepackaged food,Healthy food,food,medical instruments,Edible produce,fruits and vegetables,Melons,Sales of agricultural and sideline products;Health Information Consultation;food technology transfer;Food technology development for biotechnology;Pre-packaged food,Health food research and development(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Amicogen, Inc. engages in the development and sale of enzyme products and functional food materials. Its products include specialty enzyme for pharmaceutical, food, feed, and industrial; new bio-ingredients such as natural health ingredients for food, feed and cosmetics; and immunological products such as protein A resin. The company was founded on May 29, 2000 and is headquartered in Jinju-si, South Korea.

Hadasit is the technology transfer company of Hadassah Medical Center in Jerusalem. They transform the cutting-edge research coming out of Hadassah into marketable medical technologies. They turn ground-breaking ideas into viable products and services that can change the world and better humanity. For more than a century, Hadassah has set the standard of excellence for medical care and research in Israel. Their doctors and scientists are on the frontlines, uniquely positioned to pinpoint ever-evolving medical needs. Their experience and ingenuity has yielded new ideas with huge potential in all areas of medicine, including therapeutics, diagnostic medical devices, and digital health. More than half of all hospital research in Israel is conducted at Hadassah. Hadasit is Hadassah’s vehicle for commercialization of the intellectual property and R&D capabilities developed there. Hadasit holds exclusive rights to every innovation and invention emerging from Hadassah and they are dedicated to bringing these life-saving technologies to the general public.